Business Wire

Seoul Semiconductor's LED SunLike Improves Eye Health and Sleep Quality, According to Clinical Study

Jaa

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global market leader in LED (light emitting diode) design and manufacturing, announced that a research has shown that its “SunLike” is an optimized LED for human centric lighting that improves eye health and sleep quality.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180712005307/en/

SunLike spectrum that lowered the blue light peak, which is an optimized LED for human centric light ...

SunLike spectrum that lowered the blue light peak, which is an optimized LED for human centric lighting (Graphic: Business Wire)

The research team of Biomedical Information Laboratory, Seoul National University College of Medicine in Korea, has reported that using SunLike based lighting, the eye discomfort is significantly reduced and the sleep quality is improved compared to conventional LED lighting users.

The researchers conducted experiments on adults including graduate students at Seoul National University, who spend a lot of time studying at their desk indoors. Each participant was instructed to use SunLike desk lamp and conventional LED lamp for 3 hours before bedtime. The team conducted a questionnaire and analyzed the vital signs of participants recorded during sleep.

Subjective evaluation through questionnaires showed a significant decrease in eye fatigue and a marked improvement in sleep quality. The researchers found that improvement of the feeling of not refreshing after a sleep in the following morning was statistically significant.

As a result of analyzing the measured vital sign, the time it takes to fall asleep is 23% faster and the time to break during sleep was also improved by 43%. Therefore, the research team found that sleep efficiency as an indicator of sleep was significantly improved from 88% to 94%.

“We conclude that these effects are due to the stabilization of the autonomic nervous system rhythm, which is manifested by inactivation of sympathetic nerve and activity of parasympathetic nerve by SunLike based lighting,” said the research team of SNU. “Light affects people’s circadian rhythm. In order to improve biorhythm, we can adjust the light according to time zone and use a light source close to sunlight,” said the research team of SNU.

SunLike is an advanced light source that combines the latest optical and compound semiconductor technology of Seoul Semiconductor and *TRI-R technology, a sunlight spectrum reproduction technology, that is a registered trademark by the Toshiba Materials Co., Ltd. It that lowers blue light peak similar to sunlight spectrum contributes to maintaining a stable human circadian rhythms and enhancing the color clarity of objects.

In addition, as a result of analyzing the blue light emitted by the LED ‘SunLike’, it received Eye Safety Certification for level RG-1, the highest level of safety, from Korea Testing & Research Institute last November. This is the level given to a safe light source without any photobiological hazards.

“Since its launch on June 29th, last year in Frankfurt, Germany, with Toshiba Materials Co., Ltd., SunLike has being supplied to global customers in US, Europe, China and Japan that manufacture home lightings, smart desk stands and lamps. It is also currently working on more than 200 projects for SunLike with customers, suppliers and researchers,” said Minsoo Son, marketing vice president of Seoul Semiconductor. “We will prove SunLike is the innovative LED which adds value for human centric lighting by demonstrating differentiated quality and competitiveness to exceed customers’ expectations.”

*TRI-R, supported by Toshiba Materials, finds in the definition “The light closest to the sun for human well-being” as its original concept. The sun light spectrum is developed by the same company and can be reproduced by a white LED light source technology.

About Seoul Semiconductor
Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC. To learn more, visit www.seoulsemicon.com.

Contact information

Seoul Semiconductor Co., Ltd.
Korea and Asia
Jeonghee Kim
+82-70-4391-8311
+82-10-4843-6303
jeonghee.kim@seoulsemicon.com
Americas
Andrew Smith
+1 (901) 831-6614
andrew.smith@seoulsemicon.com
China
Vincent Wu
+86-1391-7898226
vincent.wu@seoulsemicon.com
Europe
Marc Juarez
+49 89 450 36 90 31
marc.juarez@seoulsemicon.com
Japan
Kohei Shimooka
+81-80-4668-9710
kohei.shimooka@seoulsemicon.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

SCG Chemicals Company chooses gPROMS modelling for digital design and operations22.3.2019 18:55:00 EETTiedote

Process Systems Enterprise (PSE), the Advanced Process Modelling company, today announced that it has signed a long-term agreement with SCG, one of the largest integrated petrochemical companies in South East Asia, to standardise on PSE’s gPROMS® modelling technology for digital design and operations. SCG applies advanced process models within digital design initiatives to explore the process decision space rapidly and effectively, in order to reduce uncertainty and make better, faster and safer design and operating decisions. This help them to accelerate innovation and optimise the design and operation of their process plants. Dr Suracha Udomsak, SCG’s Emerging Business Director and R&D Director, says, “at SCG Chemicals, advanced process modelling (APM) is a key element in our Digital Manufacturing platform. APM accelerates innovation by making the development workflow ‘faster, cheaper & safer’, which are key considerations for us. It is a core technology building block that enables u

Logicor Announces Results for Year Ended 31 December 201822.3.2019 17:29:00 EETTiedote

Logicor announces strong financial performance for the year ended 31 December Net Operating Income (NOI): €639 million, which represents year on year growth of 2.5%, reflecting our strategic focus on increasing occupancy and capturing market rental growth. Over 60% of NOI is generated in the key markets of the UK (26%), Northern Europe1 (21%) and France (15%). Gross Asset Value: €12.5 billion, a 3.3% increase in valuation, which reflects the strong performance of our portfolio, in particular in Northern Europe. EPRA Occupancy: 94.4%, with physical occupancy up 70 bps over the year, underpinned by strong growth in each of our three largest regions of the UK (+120 bps), Northern Europe (+110 bps) and France (+220 bps). LTV: 51%, down from 52% at year end 2017 following increases in property values. At year end, our debt to EBITDA ratio was 11.3x. Capital Structure In 2018 Logicor (rated BBB (Stable) by S&P) established a Euro Medium Term Note (‘EMTN’) programme and raised €1.8 billion of

Delticom AG/Mytyres.co.uk: Buying Great Value Tyres Online Doesn’t Mean Missing out on Professional Fitting22.3.2019 17:15:00 EETTiedote

Spring is just around the corner, and it’s time for drivers to start thinking about changing to summer tyres. However, a tyre check may show that your current summer tyres are getting old, worn out, or have visible damage, such as cracks or bumps. If this is the case, then it's time for a new set of tyres. The legal minimum tread depth is 1.6 mm, however experts recommend significantly more – summer tyres should be replaced even if the tread depth is 3 mm. Regardless of mileage, you should change your tyres at least every eight to ten years. This is because the rubber starts to harden, the tyres lose grip on the road, and driving performance is affected. Of course, a set of four new tyres is a significant investment – authorised workshops can often charge between 250 and 350 pounds. If you want to save money, consider the alternatives: the result is an increasing number of customers turning to online shops such as Mytyres.co.uk to buy new tyres. The market share of tyres sold online ha

Trueman Man Clinic Achieves 10000 Surgery Milestone with Its SWITCH Operation22.3.2019 16:00:00 EETTiedote

Trueman Man Clinic Network announced that the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation), has been successfully completed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190322005013/en/ Trueman Man Clinic Network has been successfully completed the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation). The SWITCH Premature Ejaculation Surgery (SWITCH operation) developed in 2010 by Dr. Yang, the chief director of the Trueman Man Clinic Network, can reduce the side effects of penile neurectomy and maintain the stable reduction of the glans sensation. The Trueman Man Clinic Network is the leading hospitals for male enhancement surgeries in Korea consists of 11 clinics, with 16 doctors working. As of 2019, more than 43,000 man clinic surgeries have been performed. (Photo: Business Wire) The Trueman Man Clinic Network is the leading hospitals for m

Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible22.3.2019 14:22:00 EETTiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Type II variation application to the European Medicines Agency (EMA) for DARZALEX®▼ (daratumumab) in combination with lenalidomide and dexamethasone (Rd) for the treatment of patients newly diagnosed with multiple myeloma who are ineligible for autologous stem cell transplant (ASCT). “Today’s submission brings us one step closer to our goal of improving treatment outcomes for people newly diagnosed with multiple myeloma,” said José Antonio Burón Vidal, VP Medical Affairs, Europe, Middle East and Africa (EMEA), Janssen-Cilag Limited. “We are incredibly grateful to the patients and investigators who participated in the MAIA clinical trial programme and look forward to working closely with the regulatory authorities to secure approval of this new combination.” The submission is supported by data from the Phase 3 MAIA (MMY3008) study, which were presented at the 60th Annual Meeting of the American

Bartek Ingredients Expands Leadership Team22.3.2019 01:35:00 EETTiedote

Bartek Ingredients Inc. recently completed a 4,000 ton/year capacity expansion for its malic and food-grade fumaric acid production facility, and today it announces the expansion of its leadership team, with the hiring of Jeff Billig as Vice President of Marketing & Business Development and Heinrich G. Schaefer as International Sales Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005785/en/ The global leader in malic and fumaric acid ingredients expands its leadership team. (Photo: Business Wire) Bartek’s investment in both its team and facilities reinforces its position as the leader in malic and fumaric acid globally and aligns with its mission to facilitate growth and increase global reach to better serve existing customers and markets while opening up new ones. Bartek’s addition of Billig and Schaefer lays the foundation for additional resource investment in the near future while rapidly increasing its sa

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme